- Sponsored Content
- Manufacturing
BPI Contributor
January 29, 2015
20 Min View
Date: Jan 29, 2015
Duration: 20 Min
Sponsored by BioGenes
This webcast features: Jamina Fiedler, Head of 2D Analytics at BioGenes GmbH.
Biopharmaceutical products need to be free of contaminating host cell proteins (HCPs) prior to approval and regulatory bodies ask for a clear and manifest proof that HCP assays are fit for purpose. The colorimetric 2D Western Blot method, although widely used for HCP detection and coverage determination, has several limitations. Using examples, webinar participants will learn how the use of fluorescent dyes can help overcome these limitations to meet the increasing regulatory requirements.
About the Author(s)
You May Also Like